Specificity tuning of antibody fragments to neutralize two human chemokines with a single agent

被引:17
作者
Fagete, Severine [1 ]
Ravn, Ulla [1 ]
Gueneau, Franck [1 ]
Magistrelli, Giovanni [1 ]
Kosco-Vilbois, Marie H. [1 ]
Fischer, Nicolas [1 ]
机构
[1] NovImmune SA, CH-1228 Plan Les Ouates, Switzerland
关键词
cross-reactive antibody; antibody arrays; chemotaxis; multiple targeting; affinity maturation; phage display; ANTIGEN INTERACTIONS; MOLECULAR EVOLUTION; CROSS-REACTIVITY; RECEPTOR CXCR3; INHIBITION; CELLS; CHEMOATTRACTANT; INFLAMMATION; RECRUITMENT; BLOCKADE;
D O I
10.4161/mabs.1.3.8527
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chemokines are important mediators of the immune response that are responsible for the trafficking of immune cells between lymphoid organs and migration towards sites of inflammation. Using phage display selection and a functional screening approach, we have isolated a panel of single-chain fragment variable (scFv) capable of neutralizing the activity of the human chemokine CXCL10 (hCXCL10). One of the isolated scFv was weakly cross-reactive against another human chemokine CXCL9, but was unable to block its biological activity. We diversified the complementarity determining region 3 (CDR3) of the light chain variable domain (VL) of this scFv and combined phage display with high throughput antibody array screening to identify variants capable of neutralizing both chemokines. Using this approach it is therefore possible to engineer pan-specific antibodies that could prove very useful to antagonize redundant signaling pathways such as the chemokine signaling network.
引用
收藏
页码:288 / 296
页数:9
相关论文
共 28 条
[1]   Chemokine: Receptor structure, interactions, and antagonism [J].
Allen, Samantha J. ;
Crown, Susan E. ;
Handel, Tracy M. .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :787-820
[2]   IN-VITRO EVOLUTION OF A NEUTRALIZING HUMAN-ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO ENHANCE AFFINITY AND BROADEN STRAIN CROSS-REACTIVITY [J].
BARBAS, CF ;
HU, D ;
DUNLOP, N ;
SAWYER, L ;
CABABA, D ;
HENDRY, RM ;
NARA, PL ;
BURTON, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3809-3813
[3]   Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation [J].
Charo, IF ;
Ransohoff, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :610-621
[4]   Structure-function relationship between the human chemokine receptor CXCR3 and its ligands [J].
Clark-Lewis, I ;
Mattioli, I ;
Gong, JH ;
Loetscher, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (01) :289-295
[5]   Human interferon-inducible 10-kDa protein and human interferon-inducible T cell α chemoattractant are allotopic ligands for human CXCR3:: Differential binding to receptor states [J].
Cox, MA ;
Jenh, CH ;
Gonsiorek, W ;
Fine, J ;
Narula, SK ;
Zavodny, PJ ;
Hipkin, RW .
MOLECULAR PHARMACOLOGY, 2001, 59 (04) :707-715
[6]  
DE KJ, 2007, ANNU REV MED, V58, P359
[7]   Antibody arrays for high-throughput screening of antibody-antigen interactions [J].
de Wildt, RMT ;
Mundy, CR ;
Gorick, BD ;
Tomlinson, IM .
NATURE BIOTECHNOLOGY, 2000, 18 (09) :989-994
[8]   Structure junction, and inhibition of chemokines [J].
Fernandez, EJ ;
Lolis, E .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 :469-499
[9]   Bispecific antibodies:: Molecules that enable novel therapeutic strategies [J].
Fischer, Nicolas ;
Leger, Olivier .
PATHOBIOLOGY, 2007, 74 (01) :3-14
[10]   Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin [J].
Garcia-Rodriguez, Consuelo ;
Levy, Raphael ;
Arndt, Joseph W. ;
Forsyth, Charles M. ;
Razai, Ali ;
Lou, Jianlong ;
Geren, Isin ;
Stevens, Raymond C. ;
Marks, James D. .
NATURE BIOTECHNOLOGY, 2007, 25 (01) :107-116